Ni W - Search Results

1

Budget Impact Analysis of a Pharmacist-Provided Transition of Care Program.

Ni W, Colayco D, Hashimoto J, Komoto K, Gowda C, Wearda B, McCombs J. Ni W, et al. J Manag Care Spec Pharm. 2018 Feb;24(2):90-96. doi: 10.18553/jmcp.2018.24.2.90. J Manag Care Spec Pharm. 2018. PMID: 29384028 Free PMC article.

2

Impact of a pharmacy-based transitional care program on hospital readmissions.

Ni W, Colayco D, Hashimoto J, Komoto K, Gowda C, Wearda B, McCombs J. Ni W, et al. Am J Manag Care. 2017 Mar;23(3):170-176. Am J Manag Care. 2017. PMID: 28385023 Free article.

3

Reduction of healthcare costs through a transitions-of-care program.

Ni W, Colayco D, Hashimoto J, Komoto K, Gowda C, Wearda B, McCombs J. Ni W, et al. Am J Health Syst Pharm. 2018 May 15;75(10):613-621. doi: 10.2146/ajhp170255. Epub 2018 Apr 12. Am J Health Syst Pharm. 2018. PMID: 29650726

4

Health Care Utilization and Treatment Persistence Associated with Oral Paliperidone and Lurasidone in Schizophrenia Treatment.

Jiang Y, Ni W. Jiang Y, et al. Among authors: ni w. J Manag Care Spec Pharm. 2015 Sep;21(9):780-92. doi: 10.18553/jmcp.2015.21.9.780. J Manag Care Spec Pharm. 2015. PMID: 26308225 Free PMC article.

5

Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization.

Jiang Y, Ni W. Jiang Y, et al. Among authors: ni w. Pharmacotherapy. 2015 Sep;35(9):813-22. doi: 10.1002/phar.1634. Pharmacotherapy. 2015. PMID: 26406773

6

Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.

Xuan S, Zangwill KM, Ni W, Ma J, Hay JW. Xuan S, et al. Among authors: ni w. J Gen Intern Med. 2020 Apr;35(4):1102-1110. doi: 10.1007/s11606-019-05487-5. Epub 2020 Feb 3. J Gen Intern Med. 2020. PMID: 32016703 Free PMC article.

7

Comparison of health services use associated with ziprasidone and olanzapine among schizophrenia and bipolar disorder patients in the USA.

Jiang Y, Ni W, McGinnis JJ. Jiang Y, et al. Among authors: ni w. Clin Drug Investig. 2014 Jul;34(7):491-9. doi: 10.1007/s40261-014-0202-5. Clin Drug Investig. 2014. PMID: 24858912

8

Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: an economic modelling analysis.

Jiang Y, Ni W, Wu J. Jiang Y, et al. Among authors: ni w. BMJ Open. 2019 Nov 24;9(11):e031186. doi: 10.1136/bmjopen-2019-031186. BMJ Open. 2019. PMID: 31767588 Free PMC article.

9

Economic Evaluation of the 2016 Chinese Guideline and Alternative Risk Thresholds of Initiating Statin Therapy for the Management of Atherosclerotic Cardiovascular Disease.

Jiang Y, Ni W. Jiang Y, et al. Among authors: ni w. Pharmacoeconomics. 2019 Jul;37(7):943-952. doi: 10.1007/s40273-019-00791-8. Pharmacoeconomics. 2019. PMID: 30875022

10

Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective.

Ni W, Liu J, Jiang Y, Wu J. Ni W, et al. BMC Ophthalmol. 2021 May 24;21(1):229. doi: 10.1186/s12886-021-01997-1. BMC Ophthalmol. 2021. PMID: 34024275 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,042 results

Search Page

Filters